RMD
ResMed Inc.Healthcare · $32.1B market cap
Verdict
Share price
$218.89
close of Oct 3, 2026
Fair value
$187.09
Sticker Price
Payback Price
$74.83
buy price
RMD is Overpriced: at $218.89 it trades 17% above its fair value of $187.09. Its buy price (Payback Price) is $74.83, 66% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 10% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow RMD
Get notified when it reaches its buy price of $74.83. Free.
Create a free accountSuperinvestors
1 of the investors we track holds RMD. In Q2 2026, 1 added. Who we track
Moves in Q2 2026
Added: Francois Rochon
Insider activity
Since Jul 7, 2026: no open-market purchases, 5 sales worth $5.3M and 3 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Farrell Michael J.
Chairman and CEO · 2026-09-08
Sold
$1.1M
FARRELL PETER C
director · 2026-09-02
Sold
$228K
Farrell Michael J.
Chairman and CEO · 2026-08-07
Sold
$1.0M
FARRELL PETER C
director · 2026-08-05
Sold
$1.8M
Farrell Michael J.
Chairman and CEO · 2026-07-07
Sold
$1.1M
Other filings
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works